Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 770.75 INR
Change Today +4.25 / 0.55%
Volume 21.3K
As of 6:11 AM 10/6/15 All times are local (Market data is delayed by at least 15 minutes).

novartis india ltd (HCBA) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/20/15 - 982.00
52 Week Low
03/27/15 - 539.95
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NOVARTIS INDIA LTD (HCBA)

Related News

No related news articles were found.

novartis india ltd (HCBA) Related Businessweek News

No Related Businessweek News Found

novartis india ltd (HCBA) Details

Novartis India Limited manufactures and sells healthcare products in India and internationally. It operates through four segments: Pharmaceuticals, Generics, Over-The-Counter, and Animal Health. The Pharmaceuticals segment offers a portfolio of prescription medicines through healthcare professionals. The Generics segment offers retail generics products in various therapeutic areas, such as anti-TB, anti-DUB (gynecology), anti-histamines, antibiotics, anti-ulcerants, anti-diabetes, and cardiovascular. The Over-The-Counter segment offers vitamins, minerals, and nutritional supplements, as well as products for the treatment of cough, cold, and allergy. The Animal Health segment offers products for the cattle and poultry markets. The company was founded in 1947 and is based in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.

1,207 Employees
Last Reported Date: 05/27/15
Founded in 1947

novartis india ltd (HCBA) Top Compensated Officers

Managing Director, Vice Chairman, Chairman of...
Total Annual Compensation: 17.0M
Chief Financial Officer
Total Annual Compensation: 7.5M
Whole Time Director, Member of Corporate Soci...
Total Annual Compensation: 5.3M
Compliance Officer and Company Secretary
Total Annual Compensation: 4.7M
Executive Officer
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

novartis india ltd (HCBA) Key Developments

Novartis India Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2015

Novartis India Limited announced unaudited standalone earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported net sales were INR 2,159.69 million against INR 2,020.6 million a year ago. Profit from operations before other income and finance costs was INR 3.5 million against loss from operations before other income and finance costs of INR 40.2 million a year ago. Profit from ordinary activities before tax was INR 205.7 million against INR 208.0 million a year ago. Net profit was INR 134.5 million against INR 143.1 million a year ago. Diluted earnings per share before and after extraordinary items were INR 4.21 against INR 4.48 a year ago.

Novartis India Limited, Board Meeting, Jul 22, 2015

Novartis India Limited, Board Meeting, Jul 22, 2015. Agenda: To consider quarterly results.

Novartis AG Reportedly Mulls Acquisition Of Novartis India

Novartis AG (SWX:NOVN) is mulling the acquisition of remaining stake in Novartis India Limited (BSE:500672) and delisting it, sources informed. Novartis executives met investment banks to discuss the procedures if it decides to pursue the delisting, sources said. Dermot Doherty, a spokesman for Novartis, declined to comment to Bloomberg.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HCBA:IN 770.75 INR +4.25

HCBA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HCBA.
View Industry Companies

Industry Analysis


Industry Average

Valuation HCBA Industry Range
Price/Earnings 30.3x
Price/Sales 3.1x
Price/Book 2.4x
Price/Cash Flow 29.1x
TEV/Sales 2.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS INDIA LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at